Large-scale testing (Phase 3)Study completedNCT03212521
What this trial is testing
Efficacy and Safety of 8-weeks of Glecaprevir/Pibrentasvir in Treatment-Naïve Adults With HCV Genotype 1-6 and Aspartate Aminotransferase to Platelet Ratio Index (APRI) ≤1
Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 230